Microdialysis evaluation of the ocular pharmacokinetics of propranolol in the conscious rabbit

Pharmaceutical Research

Volumn 16, Issue 5, 1999, Pages 736-742

  Rittenhouse, Kay D ^a   Peiffer Jr , Robert L ^b   Pollack, Gary M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

adrenergic antagonist; Anesthesia; Aqueous humor; Microdialysis; Ocular pharmacokinetics; Propranolol; Protein binding

Indexed keywords

EYE PROTEIN; HUMAN SERUM ALBUMIN; OROSOMUCOID; PROPRANOLOL; TRITIUM;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; AREA UNDER THE CURVE; ARTICLE; CONSCIOUSNESS; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG TISSUE LEVEL; EYE; HUMAN; HUMAN TISSUE; MICRODIALYSIS; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RABBIT; TOPICAL DRUG ADMINISTRATION;

ADRENERGIC BETA-AGONISTS; ANESTHETICS, DISSOCIATIVE; ANIMALS; AQUEOUS HUMOR; CONSCIOUSNESS; KETAMINE; LEAST-SQUARES ANALYSIS; MICRODIALYSIS; PROPRANOLOL; PROTEIN BINDING; RABBITS; TRITIUM; ULTRAFILTRATION;

EID: 0032912117     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018884826943     Document Type: Article

References (26)

1. 1. J. Waga, A. Ohta, and B. Ehinger. Intraocular microdialysis with permanently implanted probes in rabbit. ACTA Ophthalmologica. 69:618-624 (1991).
2. 2. J. Ben-Nun, D. A. Joyce, R. L. Cooper, and S. J. Cringle. Pharmacokinetics of intravitreal injection. Invest. Ophthalmol. Vis. Sci. 30:1055-1061 (1989).
3. 3. N. Stempels, M-J. Tassignon, and S. Sarre. A removable ocular microdialysis system for measuring vitreous biogenic amines. Graefe's Arch. Clin. Exp. Ophthalmol. 231:651-655 (1993).
4. 4. P. Louzada-Junior, J. J. Dias, W. F. Santos, J. J. Lachat, H. F. Bradford, and J. Coutinho-Netto. Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J. Neurochem. 59:358-363 (1992).
5. 3H]Acetylaspar-tylglutamate from the optic pathway. J. Neurochem. 51:1956-1959 (1998).
6. 6. H. Sato, S. Fukuda, M. Inatomi, R. Koide, N. Uchida, Y. Kanda, Y. Kiuchi, and K. Oguchi. Pharmacokinetics of norfloxacin and lomefloxacin in domestic rabbit aqueous humor analyzed by microdialysis. J. Jpn. Ophthalmol. 7:513-519 (1995).
7. 7. K. D. Rittenhouse, R. L. Peiffer Jr., and G. M. Pollack. Evaluation of microdialysis sampling of aqueous humor for in vivo models of ocular absorption and disposition. J. Pharm. Biomed. Anal. 16:951-959 (1998).
8. 8. R. Ohtori, H. Sato, S. Fukuda, T. Ueda, R. Koide, Y. Kanda, Y. Kiuchi, and K. Oguchi. Pharmacokinetics of topical beta-adrenergic antagonists in rabbit aqueous humor evaluated with the microdialysis method. Exp. Eye. Res. 66:487-494 (1998).
9. 9. E. Noack. Treatment of glaucoma with beta-receptor blockers. Significance of adrenergic receptors of the beta-2 subtype for their effect on intraocular pressure. Ophthalmologica. 196:76-81 (1988).
10. 10. F. E. Ross, H. C. Innemee, and P. A. Van Zwieten. Ocular penetration of β-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol. Documenta Ophthalmoligica. 48:291-301 (1979).
11. 11. D. F. Cole. Secretion of the aqueous humor. Exp. Eye Res. 25 (suppl.):161-176 (1977).
12. 12. P. S. Kulkarni and B. D. Srinvasan. Nonsteroidal anti-inflammatory drugs in ocular inflammatory conditions in: A. J. Lewis, D. E. Furst eds., Nonsteroidal Anti-Inflammatory Drugs. Marcel Dekker, New York, 1987.
13. 13. M. Rowland and T. N. Tozer. Clinical Pharmacokinetics: Concepts and Applications. 3rd ed. Media, PA: Williams and Wilkins, 1995.
14. 14. L. L. Stale in: Robinson LE, Justice JB Jr., eds. Microdialysis in the Neurosciences. Amsterdam: Elsevier, 1991.
15. 15. O. H. Lowry, J. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
16. 16. J. D. Wright, F. D. Boudinot, and M. R. Ujhelyi. Measurement and analysis of unbound drug concentrations. Clin Pharmacokinet. 30:445-462 (1996).
17. 17. M. Gibaldi and D. Perrier. Pharmacokinetics, 2nd ed. New York: Marcel Dekker, 1982.
18. 18. A. M. Herrera, D. O. Scott, and C. E. Lunte. Microdialysis sampling for determination of plasma protein binding of drugs. Pharm. Res. 7:1077-1081 (1990).
19. 19. S. Glasson, R. Zini, P. D'Athis, J. P. Tillement, and J. R. Boissier. The distribution of bound propranolol between different human serum proteins. Mol. Pharmacol. 17:187-191 (1980).
20. 20. Masuda K, Izawa Y, and Mishima S. Breakdown of the blood:aqueous barrier and prostaglandins. Bibliotheca Anatomica. 16:99-104 (1977).
21. 21. E. Latoure, J. Y. Driot, C. Coquelet, and C. Bonne. The role of platelets in blood-aqueous barrier breakdown induced by anterior paracentesis in the rabbit. Curr. Eye Res. 8:1105-1110 (1989).
22. 22. M. M. Tahery and D. A. Lee. Review: pharmacologic control of would healing in glaucoma filtration surgery. J. Ocul. Pharmacol. 5:155 (1989).
23. 23. C. Schmitt, V. J. Lotti, and J. C. LeDovarec. Penetration of five beta-adrenergic antagonists into the rabbit eye after ocular instillation. Albrecht von Graefes Arch. Klin. Ophthalmol. 217:167-174 (1981).
24. 24. A. Hussain, S. Hirai, and J. Sieg. Ocular absorption of propranolol in rabbits. J. Pharm. Sci. 69:738-739 (1980).
25. 25. J. W. Sieg and J. R. Robinson. Vehicle effect on ocular drug bioavailability I: evaluation of fluorometholone. J. Pharm. Sci. 64:931-936 (1980).
26. 26. S. S. Chrai, T. F. Patton, A. Mehta, and J. R. Robinson. Lacrimal and instilled fluid dynamics in rabbit eyes. J. Pharm. Sci. 62:1112-1121 (1973).